ClinicalTrials.gg
RecruitingNCT07821034Updated Sep 21, 2026

Effects of Reiki Therapy in Women With Fibromyalgia

An interventional study of Reiki Intervention and Sham Reiki Intervention in Fibromyalgia (FM) OR Fibromyalgia Syndrome, sponsored by Federal University of the Valleys of Jequitinhonha and Mucuri. Recruiting at 1 site in Brazil. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-21.

Sponsored by Federal University of the Valleys of Jequitinhonha and Mucuri · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Sep 2025, registered Sep 2026).
  • Started Sep 2025; still recruiting 1 year 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
84
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The goal of this randomized clinical trial is to evaluate the effects of a 4-week Reiki therapy program in women with fibromyalgia. The main questions it aims to answer are:

Does Reiki therapy lead to a greater change in pain intensity compared with a placebo intervention after 4 weeks of treatment?

Does Reiki therapy lead to a greater change in the impact of fibromyalgia compared with a placebo intervention after 4 weeks of treatment?

Researchers will also evaluate whether Reiki therapy affects depressive symptoms, anxiety symptoms, sleep quality, and acute changes in pain intensity, heart rate, and respiratory rate.

Researchers will compare participants receiving Reiki therapy with participants receiving a placebo intervention to determine whether changes in these outcomes differ between groups.

Participants will:

be randomly assigned to either the Reiki therapy group or the placebo group; receive one 30-minute intervention session per week for 4 weeks; complete assessments of pain intensity, fibromyalgia impact, depressive symptoms, anxiety symptoms, and sleep quality before and after the 4-week intervention period; have pain intensity, heart rate, and respiratory rate assessed immediately before and after each intervention session to evaluate acute responses.

02

Conditions studied

  • Fibromyalgia (FM) OR Fibromyalgia Syndrome

Browse trials for

Keywords

  • Fibromyalgia
  • Reiki
03

In context

Fibromyalgia

1,243 studies on the registry are indexed under Fibromyalgia; 256 are open to participants now.

This study's planned enrollment of 84 is above the median of 60 across 937 interventional studies indexed under Fibromyalgia.

Browse Fibromyalgia studies →

Lead sponsor

Federal University of the Valleys of Jequitinhonha and Mucuri is the lead sponsor of 21 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female participants aged 18 years or older.
  • Medical diagnosis of fibromyalgia, confirmed according to the 2016 American College of Rheumatology (ACR) criteria using the Brazilian version of the Fibromyalgia Survey Questionnaire (FSQ-Brazil).

Exclusion criteria

Exclusion Criteria:

  • Clinically unstable medical condition.
  • Presence of acute injuries.
  • Pregnancy.
  • Cognitive impairment or any other condition that prevents the participant from completing the study questionnaires.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
84 participants (estimated)

Study arms

  • Placebo comparator
    Sham Reiki Group

    Participants assigned to this arm will be positioned under the same conditions as participants in the Reiki Intervention Group and will remain in the intervention setting for 30 minutes; however, no hand imposition or Reiki intervention will be administered. Sessions will occur once weekly for 4 weeks

    Other: Sham Reiki Intervention

  • Experimental
    Reiki Therapy Group

    Participants assigned to this arm will receive a 30-minute Reiki intervention through hand imposition, once weekly for 4 weeks.

    Other: Reiki Intervention

Interventions

  • OtherReiki Intervention

    Participants assigned to this arm will receive Reiki therapy through hand imposition for 30 minutes, once weekly for 4 weeks.

  • OtherSham Reiki Intervention

    Participants assigned to this arm will be positioned under the same conditions as participants in the Reiki Intervention Group and will remain in the intervention setting for 30 minutes; however, no hand imposition or Reiki intervention will be administered. Sessions will occur once weekly for 4 weeks.

06

What researchers measure

Primary outcomes

  1. Change From Baseline in Pain Intensity After 4 Weeks

    Pain intensity will be assessed using the Visual Analog Scale (VAS). Participants will rate their current pain intensity on a scale ranging from 0 to 10, with higher scores indicating greater pain intensity. Change from baseline to the end of the 4-week intervention period will be evaluated.

    Time frame: Baseline and 4 weeks

  2. Change From Baseline in Fibromyalgia Impact After 4 Week

    The impact of fibromyalgia will be assessed using the Revised Fibromyalgia Impact Questionnaire (FIQR). The total score ranges from 0 to 100, with higher scores indicating greater impact of fibromyalgia on health and daily functioning. Change from baseline to the end of the 4-week intervention period will be evaluated.

    Time frame: Baseline and 4 weeks

Secondary outcomes

  1. Change From Baseline in Depressive Symptoms After 4 Weeks

    Depressive symptoms will be assessed using the Beck Depression Inventory. The total score ranges from 0 to 63, with higher scores indicating greater severity of depressive symptoms. Change from baseline to the end of the 4-week intervention period will be evaluated.

    Time frame: Baseline and 4 weeks

  2. Change From Baseline in Anxiety Symptoms After 4 Weeks

    Anxiety symptoms will be assessed using the Beck Anxiety Inventory. The total score ranges from 0 to 63, with higher scores indicating greater severity of anxiety symptoms. Change from baseline to the end of the 4-week intervention period will be evaluated.

    Time frame: Baseline and 4 weeks

  3. Change From Baseline in Sleep Quality After 4 Weeks

    Sleep quality will be assessed using the Pittsburgh Sleep Quality Index. The global score ranges from 0 to 21, with higher scores indicating poorer sleep quality. Change from baseline to the end of the 4-week intervention period will be evaluated.

    Time frame: Baseline and 4 weeks

  4. Acute Change in Pain Intensity Following Intervention Sessions

    Pain intensity will be assessed using the Visual Analog Scale (VAS) immediately before and immediately after each intervention session. Scores range from 0 to 10, with higher scores indicating greater pain intensity. Acute pre-to-post-session changes will be evaluated across the four weekly sessions.

    Time frame: Immediately before and immediately after each of the four weekly intervention sessions

  5. Acute Change in Heart Rate Following Intervention Sessions

    Heart rate will be measured in beats per minute immediately before and immediately after each intervention session. Acute pre-to-post-session changes will be evaluated across the four weekly sessions.

    Time frame: Immediately before and immediately after each of the four weekly intervention sessions

  6. Acute Change in Respiratory Rate Following Intervention Sessions

    Respiratory rate will be measured in breaths per minute immediately before and immediately after each intervention session. Acute pre-to-post-session changes will be evaluated across the four weekly sessions.

    Time frame: Immediately before and immediately after each of the four weekly intervention sessions

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07821034
Lead sponsor
Federal University of the Valleys of Jequitinhonha and Mucuri
Responsible party
Sponsor
First posted
Sep 15, 2026
Start date
Sep 18, 2025
Primary completion
Dec 15, 2026 (estimated)
Completion
Dec 20, 2026 (estimated)
Last update
Sep 21, 2026

Study contacts

Sueli F Fonseca
Contact
sueli.fonseca@ufvjm.edu.br
55 38991802656
Ricardo A Silva
principal investigator · Federal University of the Valleys of Jequitinhonha and Mucuri
Sueli F Fonseca
study director · Federal University of the Valleys of Jequitinhonha and Mucuri

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion